Careers

Diversity

With 17 offices, from New York to Los Angeles and Seattle to Orlando, we live and work in communities all over the U.S., collaborating across locations, disciplines and even borders. Our experienced, highly ranked lawyers serve businesses wherever they are and wherever they want to go.

Offices

About Us

Pages

Professionals

Thought leadership: blogs, podcasts, videos, publications, events and news

Insights

Services

Pro Bono

Am Law 100 firm with practices in Business, Digital Assets and Data Management, Intellectual Property, Labor & Employment, Litigation and Tax.

Home | BakerHostetler

Partners discuss FTC rulemaking, litigation at direct selling seminar

Ohio Clock

Hallway with a grandfather clock displayed

The Weekly Hill Update

PDMI Take 20: AI Series, Ep. 2 — Regulatory Implications

Artificial Intelligence

Blockchain Monitor

Crypto Products Launch for Custody, Tokenization, Staking; Crypto Adoption Report Published; DFS Proposes New VC Guidance; NFT Initiatives Announced

On March 28, 2023, Partner Lee Rosebush presents “Closing 483 Files: You Have to Ask, Dude!”  A Food and Drug Administration (FDA) Form 483 is issued to a company following an inspection in which an investigator has observed conditions that may violate the Food Drug and Cosmetic (FD&C) Act or related legislation.  Speaking before the 2023 Compounding Pharmacy Owner Summit in Point Clear, Alabama, Rosebush will help attendees understand how to use the FDA’s regulatory standards to successfully close an FDA Form 483.  <a href="https://a4pc.org/ownersummit/" target="_blank" rel="noopener">More information and to register.</a>

Lee Rosebush Explains How to Close FDA 483 Files

Featured Insights

Related Services

Featured Insights